1133-156 Results of four multicenter, phase III, magnetic resonance angiography (MRA) trials with MS-325, a blood pool contrast agent, for the detection of vascular disease in the aortoiliac, renal, and pedal regions
2004 ◽
Vol 43
(5)
◽
pp. A352
2009 ◽
Vol 62
(6)
◽
pp. 1447-1456
◽
2002 ◽
Vol 39
◽
pp. 368
1996 ◽
Vol 31
(5)
◽
pp. 288-293
◽
2010 ◽
Vol 33
(6)
◽
pp. 1135-1142
◽
Keyword(s):
1991 ◽
Vol 26
◽
pp. S42-S45
◽